Biocides

WSSA Members to Present Latest Research During Upcoming Annual Meeting of the Aquatic Plant Management Society

Retrieved on: 
Monday, June 28, 2021
Branches of biology, Articles, Biology, Weed science, WSSA, Biocides, Soil contamination, Pest control, Weed Science Society of America, Aquatic plant, Pesticide, Management

WESTMINSTER, Colo., June 28, 2021 /PRNewswire-PRWeb/ --Members of the Weed Science Society of America (WSSA) are among those leading presentations during in the upcoming 61st annual meeting of the Aquatic Plant Management Society (APMS), an event that will include both face-to-face and online sessions.

Key Points: 
  • WESTMINSTER, Colo., June 28, 2021 /PRNewswire-PRWeb/ --Members of the Weed Science Society of America (WSSA) are among those leading presentations during in the upcoming 61st annual meeting of the Aquatic Plant Management Society (APMS), an event that will include both face-to-face and online sessions.
  • In addition, those registering for the face-to-face session will have access to presentations delivered online during the virtual meeting.
  • Several WSSA members are among those scheduled to make presentations on the latest research and best practices in aquatic weed management.
  • The Aquatic Plant Management Society is an international organization of scientists, educators, students, commercial pesticide applicators, administrators and concerned individuals interested in the management and study of aquatic plants.

Cocrystal Pharma Completes IND-enabling Studies with CC-42344 for the Treatment of Seasonal and Pandemic Influenza A, Plans to initiate a Phase 1 Trial in the Third Quarter

Retrieved on: 
Wednesday, June 23, 2021
Antiviral drug, Biocides, Orthomyxoviridae, Biology

We recently completed a 14-day GLP toxicology study, which was the final pre-IND enabling step prior to advancing this potent inhibitor into a first-in-human study.

Key Points: 
  • We recently completed a 14-day GLP toxicology study, which was the final pre-IND enabling step prior to advancing this potent inhibitor into a first-in-human study.
  • There is a pressing need for new antivirals to treat influenza, as currently approved antiviral therapeutics are prone to viral resistance, added Dr. Lee.
  • CC-42344 stops the first step of viral replication by binding to a highly conserved PB2 site of the influenza polymerase complex that is essential to replication.
  • In preparing to initiate this study, we have already established a subsidiary in Australia and have selected a contract research organization.

Global Antimicrobial Coatings Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Monday, June 21, 2021
Chemicals, Plastics, Manufacturing, Antimicrobial, Biocides

The "Antimicrobial Coatings Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Antimicrobial Coatings Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
  • The global antimicrobial coatings market reached a value of US$ 3.4 Billion in 2020.
  • The global antimicrobial coatings market is expected to exhibit strong growth during the forecast period (2021-2026).
  • Antimicrobial coatings assist in maintaining the quality of a surface by obstructing the growth of microorganisms like fungi, parasites and bacteria.

IBI-Ag Completes Funding Round for its New Class of Bioinsecticides

Retrieved on: 
Monday, June 21, 2021
Biocides, Agronomy, Insects in culture, Academic disciplines, Physical sciences, Natural sciences, Biological pest control, Integrated pest management, Soil chemistry, Pesticide, Insecticide, Pest control

IBI-Ag is developing natural, single domain antibody insecticides to increase crop production without harm to farmers, consumers, and the environment.

Key Points: 
  • IBI-Ag is developing natural, single domain antibody insecticides to increase crop production without harm to farmers, consumers, and the environment.
  • The market for bioinsecticides is growing rapidly offering alternative solutions to traditional pesticides enabling integrated pest management schemes.
  • IBI-Ag is developing a new class of bioinsecticides based on naturally-derived proteins with minimal impact on people, plants, and crops.
  • The new bioinsecticides are designed to be stable in diverse environments and varying field conditions.

Significant Discovery Reveals New Antiviral Properties of Tetra Bio-Pharma's Innovative Drug ARDS-003

Retrieved on: 
Monday, June 21, 2021
Medical specialties, Health, Medicine, Antiviral drug, Biocides, Acute respiratory distress syndrome, Virus

On March 26, 2021, Tetra announced it had entered into an agreement with Targeted Pharmaceuticals to initiate additional studies on its leading drug candidate ARDS-003.

Key Points: 
  • On March 26, 2021, Tetra announced it had entered into an agreement with Targeted Pharmaceuticals to initiate additional studies on its leading drug candidate ARDS-003.
  • In other words, it clears the virus significantly better than the standard antiviral drug alone.
  • These results suggest that in addition to immunomodulator properties, ARDS-003 demonstrates strong antiviral effects in humans.
  • The College of Science at Mason is a leader in scientific discovery creating innovative solutions for the rapidly changing needs of today's world.

Appili Therapeutics Inc. Expands PRESECO Clinical Trial of Avigan®/Reeqonus™ for Mild-to-Moderate COVID-19 Patients into Mexico and Brazil

Retrieved on: 
Thursday, June 17, 2021
General Health, Infectious diseases, Health, Pharmaceutical, Clinical trials, Pharmaceutical industry, Health sciences, Antiviral drug, Biocides, Life sciences, Medication, Natural sciences, the PRESECO Clinical Trial, Avigan/Reeqonus, Appili Therapeutics, THE PRESECO CLINICAL TRIAL, AVIGAN/REEQONUS, APPILI THERAPEUTICS

With the addition of the new sites, Appili expects to complete enrollment and report top-line results by the end of September.

Key Points: 
  • With the addition of the new sites, Appili expects to complete enrollment and report top-line results by the end of September.
  • Here and abroad, physicians and government leaders have been calling for effective oral antiviral medicines to treat these patients.
  • With cases decreasing in the U.S. our clinical expansion into Brazil and Mexico will help us meet our enrollment goal.
  • As part of the expansion and prioritization of the PRESECO treatment study, Appili has ended its CONTROL trial.

Global Antimicrobial Therapeutics Markets 2021-2025: Focus on Antiviral, Antibacterial, Antifungal, & Antiparasitic - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 17, 2021
Health, General Health, Articles, Antimicrobial, Biocides, Market analysis, Biology, Health sciences, Evolutionary biology, Pharmaceuticals policy, Antimicrobial resistance

The "Global Antimicrobial Therapeutics Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Antimicrobial Therapeutics Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
  • This study identifies the rising awareness about microbial diseases as one of the prime reasons driving the antimicrobial therapeutics market growth during the next few years.
  • The report on antimicrobial therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
  • Also, the antimicrobial therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth.

Lakeland Fresh Farms Earns Non-GMO Verification

Retrieved on: 
Wednesday, June 16, 2021
Biocides, Soil contamination, Pesticide, Herbicide, Environmental science, Physical sciences, Natural sciences

The verified seal assures shoppers that every product from Lakeland Fresh Farms has completed a comprehensive third-party verification process to meet the non-GMO standard.

Key Points: 
  • The verified seal assures shoppers that every product from Lakeland Fresh Farms has completed a comprehensive third-party verification process to meet the non-GMO standard.
  • "It's easy just to say we are non-GMO," said Joe Corace, president and CEO of Lakeland Fresh Farms.
  • The verified products from Lakeland Fresh Farms include:
    Pure Romaine smooth and crisp red and green baby romaine leaves.
  • As a result, Lakeland Fresh Farms products are 100% free of pesticides and herbicides as well as animal byproducts.

Agricultural Coatings Market by Category, Seed Coating Types, Fertilizer Coating Types, Pesticide Coating Applications and Region - Global Forecast to 2026 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, June 15, 2021
Chemicals, Plastics, Agriculture, Natural Resources, Manufacturing, Physical sciences, Natural sciences, Chemistry, Materials science, Biocides, Pesticide, Soil contamination, Agriculture, Coating, Fertilizer, Controlled-release fertiliser

The "Agricultural Coatings Market by Category (Seed Coatings, Fertilizer Coatings, and Pesticide Coatings), Seed Coating Types (Polymers, Colorants, and Pellets), Fertilizer Coating Types, Pesticide Coating Applications, and Region - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Agricultural Coatings Market by Category (Seed Coatings, Fertilizer Coatings, and Pesticide Coatings), Seed Coating Types (Polymers, Colorants, and Pellets), Fertilizer Coating Types, Pesticide Coating Applications, and Region - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
  • Factors such as the rising need to increase agricultural productivity and favorable government policies and regulations are some of the factors driving the growth of agricultural coatings.
  • This in turn has increased the demand for the seed coatings market.
  • Similarly, with the growing demand for fertilizers and pesticides, the demand for fertilizer coatings and pesticide coatings is projected to increase during the forecast period.

Cidara Therapeutics to Participate in the Raymond James Human Health Innovation Conference

Retrieved on: 
Monday, June 14, 2021
Biocides, Antiviral drug

SAN DIEGO, June 14, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections, today announced that Jeffrey Stein, Ph.D., President and Chief Executive Officer, and James Levine, Chief Financial Officer, will participate in investor meetings at the Raymond James Human Health Innovation Conference, being held virtually June 21-23, 2021.

Key Points: 
  • SAN DIEGO, June 14, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections, today announced that Jeffrey Stein, Ph.D., President and Chief Executive Officer, and James Levine, Chief Financial Officer, will participate in investor meetings at the Raymond James Human Health Innovation Conference, being held virtually June 21-23, 2021.
  • Cidara is developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections.
  • The Companys portfolio is comprised of its lead antifungal candidate, rezafungin, in addition to AVCs for the prevention and treatment of influenza and other viral diseases from Cidaras proprietary Cloudbreak antiviral platform.
  • Cidara is headquartered in San Diego, California.